271 related articles for article (PubMed ID: 21128778)
1. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
[TBL] [Abstract][Full Text] [Related]
2. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: a review.
Tanas MR; Goldblum JR
Adv Anat Pathol; 2009 Nov; 16(6):383-91. PubMed ID: 19851129
[TBL] [Abstract][Full Text] [Related]
5. Unusual Signal Patterns of Break-apart FISH Probes Used in the Diagnosis of Soft Tissue Sarcomas.
Papp G; Mihály D; Sápi Z
Pathol Oncol Res; 2017 Oct; 23(4):863-871. PubMed ID: 28108880
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
8. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
Li L; Zhang M; Zhang TT; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
[No Abstract] [Full Text] [Related]
9. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.
Noujaim J; Jones RL; Swansbury J; Gonzalez D; Benson C; Judson I; Fisher C; Thway K
Br J Cancer; 2017 Feb; 116(5):669-678. PubMed ID: 28141799
[TBL] [Abstract][Full Text] [Related]
10. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
[TBL] [Abstract][Full Text] [Related]
12. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
14. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
15. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.
Hemminger JA; Iwenofu OH
Mod Pathol; 2013 Sep; 26(9):1204-10. PubMed ID: 23599152
[TBL] [Abstract][Full Text] [Related]
16. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
17. Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.
Nishio J
J Biomed Biotechnol; 2011; 2011():524067. PubMed ID: 21274402
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal translocations in human soft tissue sarcomas by interphase fluorescence in situ hybridization.
Yoshida H; Nagao K; Ito H; Yamamoto K; Ushigome S
Pathol Int; 1997 Apr; 47(4):222-9. PubMed ID: 9103213
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue.
Horn H; Allmanritter J; Doglioni C; Marx A; Müller J; Gattenlöhner S; Staiger AM; Rosenwald A; Ott G; Ott MM
Pathol Res Pract; 2014 Dec; 210(12):804-11. PubMed ID: 25446247
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]